Charting the course across the blood-brain barrier

Journal of Clinical Investigation

Volumn 121, Issue 1, 2011, Pages 31-33

  Nathanson, David ^a   Mischel, Paul S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; GANCICLOVIR; IRON; PEPTIDE; TRANSFERRIN; TRANSFERRIN RECEPTOR;

BLOOD BRAIN BARRIER; GLIOBLASTOMA; HUMAN; IN VIVO STUDY; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TRANSPORT;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; GLIOBLASTOMA; HUMANS; IRON; MICE; MOLECULAR MIMICRY; PEPTIDE LIBRARY; RECEPTORS, TRANSFERRIN; TRANSFERRIN;

EID: 78650956752     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI45758     Document Type: Note

References (21)

1. TCGA Consortium. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455(7216):1061-1068.
2. Parsons DW, et al. An integrated genomic analysis of human glioblastoma multiforme. Science. 2008; 321(5897):1807-1812.
3. Huse JT, Holland EC. Genetically engineered mouse models of brain cancer and the promise of preclinical testing. Brain Pathol. 2009;19(1):132-143.
4. Cheng CK, Fan QW, Weiss WA. PI3K signaling in glioma-animal models and therapeutic challenges. Brain Pathol. 2009;19(1):112-120.
5. Coomber BL, Stewart PA, Hayakawa K, Farrell CL, Del Maestro RF. Quantitative morphology of human glioblastoma multiforme microvessels: structural basis of blood-brain barrier defect. J Neurooncol. 1985;5(4):299-307.
6. Boockvar JA, et al. Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma [published online ahead of print October 22, 2010]. J Neurosurg. doi: 10.3171/2010.9.JNS101223.
7. Tomotaka S, Toshiyasu S, Shinji Y, Hitoshi S, Yoshiharu T, Shobu S. Transnasal delivery of anticancer drugs to the brain tumor:a new strategy for brain tumor chemotherapy. Drug Deliv Syst. 1999;14(5):365-371.
8. Fiandaca MS, Forsayeth JR, Dickinson PJ, Bankiewicz KS. Image-guided convection enhanced delivery platform in the treatment of neurological diseases. Neurotherapeutics. 2008;5(1):123-127.
9. Bidros DS, Vogelbaum MA. Novel drug delivery strategies in neuro-oncology. Neurotherapeutics. 2009;6(3):539-546.
10. Yamashita Y, et al. Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts. Neuro Oncol. 2007;9(1): 20-28.
11. Tai C, Kasahara N. Replication-competent retrovirus vectors for cancer gene therapy. Front Biosci. 2008;13:3083-3095.
12. Yong R, et al. Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas. Cancer Res. 2009;69(23):8932-8940.
13. Aboody KS, et al. Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas. Proc Natl Acad Sci U S A. 2000;97(23):12846-12851.
14. Frank RT, et al. Neural stem cells as a novel platform for tumor-specific delivery of therapeutic antibodies. PLoS ONE. 2009;4(12):e8314.
15. Pardridge WM. Blood-brain barrier delivery. Drug Discov Today. 2007;12(1-2):54-61.
16. Zhang Y, Zhang YF, Bryant J, Charles A, Boado RJ, Pardridge WM. Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer. Clin Cancer Res. 2004;10(11):3667-3677.
17. Staquicini FI, et al. Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma. J Clin Invest. 2011; 121(1):161-173.
18. Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science. 1985;228(4705):1315-1317.
19. Staquicini FI, Sidman RL, Arap W, Pasqualini R. Phage display technology for stem cell delivery and systemic therapy. Adv Drug Deliv Rev. 2010;62(12):1213-1216.
20. Kolonin MG, et al. Ligand-directed surface profiling of human cancer cells with combinatorial peptide libraries. Cancer Res. 2006;66(1):34-40.
21. Arap W, et al. Steps toward mapping the human vasculature by phage display. Nature Med. 2002; 8(2):121-127.